Literature DB >> 19523687

CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.

Jillian A Bristol1, Thomas E Morrison, Shannon C Kenney.   

Abstract

CCAAT/enhancer binding protein (C/EBP) transcription factors play essential roles in regulating an array of cellular processes, including differentiation, energy metabolism, and inflammation. In this report we demonstrate that both C/EBPalpha and C/EBPbeta activate the promoter driving transcription of the tumor necrosis factor receptor 1 (TNFR1). TNFR1 is the major receptor for tumor necrosis factor (TNF), a critical cytokine mediator of the inflammatory response. Although the TNFR1 protein has been shown to be regulated through post-translational modifications, very little is known about the transcriptional regulation of the TNFR1 gene. Here we have identified a specific C/EBP binding site within the TNFR1 promoter, and shown that this site is required for both C/EBPalpha and C/EBPbeta activation of the promoter in reporter gene assays. Furthermore, we show that both C/EBPalpha and C/EBPbeta are bound to the TNFR1 promoter in cells using chromatin immunoprecipitation assays. Finally, we demonstrate that reducing the level of C/EBPalpha and C/EBPbeta expression in cells using siRNA technology leads to decreased expression of the TNFR1 protein. These results suggest that the C/EBPalpha and C/EBPbeta transcription factors enhance expression of the TNFR1 protein in cells. Given that TNF and C/EBPbeta are known to activate each other's expression, C/EBPbeta may greatly amplify the initial TNF signal through a positive auto-regulatory mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523687      PMCID: PMC2724677          DOI: 10.1016/j.molimm.2009.05.024

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  43 in total

1.  Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.

Authors:  E R Kost; D G Mutch; T J Herzog
Journal:  Gynecol Oncol       Date:  1999-03       Impact factor: 5.482

2.  Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter.

Authors:  Ying Zuo; Li Qiang; Stephen R Farmer
Journal:  J Biol Chem       Date:  2006-01-23       Impact factor: 5.157

3.  Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.

Authors:  Jian Huang; Gangling Liao; Honglin Chen; Frederick Y Wu; Lindsey Hutt-Fletcher; Gary S Hayward; S Diane Hayward
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 4.  The role of C/EBP isoforms in the control of inflammatory and native immunity functions.

Authors:  V Poli
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

5.  DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family.

Authors:  S Osada; H Yamamoto; T Nishihara; M Imagawa
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

Review 6.  Tumor necrosis factor receptor and Fas signaling mechanisms.

Authors:  D Wallach; E E Varfolomeev; N L Malinin; Y V Goltsev; A V Kovalenko; M P Boldin
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

7.  Tumour necrosis factor-alpha regulates expression of the CCAAT-enhancer-binding proteins (C/EBPs) alpha and beta and determines the occupation of the C/EBP site in the promoter of the insulin-responsive glucose-transporter gene in 3T3-L1 adipocytes.

Authors:  R Jain; S Police; K Phelps; P H Pekala
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

8.  Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins.

Authors:  Nicolas Di-Poï; Béatrice Desvergne; Liliane Michalik; Walter Wahli
Journal:  J Biol Chem       Date:  2005-09-15       Impact factor: 5.157

9.  Amino-acid limitation induces transcription from the human C/EBPbeta gene via an enhancer activity located downstream of the protein coding sequence.

Authors:  Chin Chen; Elizabeth Dudenhausen; Hong Chen; Yuan-Xiang Pan; Altin Gjymishka; Michael S Kilberg
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

10.  C/EBP beta regulation of the tumor necrosis factor alpha gene.

Authors:  R M Pope; A Leutz; S A Ness
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

View more
  9 in total

1.  TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness.

Authors:  Laura A A Gilliam; Jennifer S Moylan; Leonardo F Ferreira; Michael B Reid
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

2.  The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins.

Authors:  Jillian A Bristol; Amanda R Robinson; Elizabeth A Barlow; Shannon C Kenney
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

3.  MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway.

Authors:  Eugene D Ponomarev; Tatyana Veremeyko; Natasha Barteneva; Anna M Krichevsky; Howard L Weiner
Journal:  Nat Med       Date:  2010-12-05       Impact factor: 53.440

4.  Single-Cell Transcriptomics-Based Study of Transcriptional Regulatory Features in the Non-Obstructive Azoospermia Testis.

Authors:  Xiao-Juan Tang; Qiao-Hong Xiao; Xue-Lin Wang; Yan He; Ya-Nan Tian; Bin-Tong Xia; Yang Guo; Jiao-Long Huang; Peng Duan; Yan Tan
Journal:  Front Genet       Date:  2022-05-20       Impact factor: 4.772

5.  Glucocorticoid-induced microRNA-511 protects against TNF by down-regulating TNFR1.

Authors:  Leen Puimège; Filip Van Hauwermeiren; Sophie Steeland; Sara Van Ryckeghem; Jolien Vandewalle; Sofie Lodens; Lien Dejager; Sofie Vandevyver; Jan Staelens; Steven Timmermans; Roosmarijn E Vandenbroucke; Claude Libert
Journal:  EMBO Mol Med       Date:  2015-08       Impact factor: 12.137

6.  Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1.

Authors:  Xiaoli Cai; Can Cao; Jiong Li; Fuquan Chen; Shuqin Zhang; Bowen Liu; Weiying Zhang; Xiaodong Zhang; Lihong Ye
Journal:  Oncotarget       Date:  2017-04-06

7.  An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.

Authors:  James C Romero-Masters; Makoto Ohashi; Reza Djavadian; Mark R Eichelberg; Mitch Hayes; Jillian A Bristol; Shidong Ma; Erik A Ranheim; Jenny Gumperz; Eric C Johannsen; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2018-08-20       Impact factor: 7.464

8.  B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.

Authors:  James C Romero-Masters; Shane M Huebner; Makoto Ohashi; Jillian A Bristol; Bayleigh E Benner; Elizabeth A Barlow; Gail L Turk; Scott E Nelson; Dana C Baiu; Nicholas Van Sciver; Erik A Ranheim; Jenny Gumperz; Nathan M Sherer; Paul J Farrell; Eric C Johannsen; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2020-02-14       Impact factor: 6.823

9.  EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.

Authors:  Chunrong Li; James C Romero-Masters; Shane Huebner; Makoto Ohashi; Mitchell Hayes; Jillian A Bristol; Scott E Nelson; Mark R Eichelberg; Nicholas Van Sciver; Erik A Ranheim; Rona S Scott; Eric C Johannsen; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2020-06-15       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.